Quarles & Brady 's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
- Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
- Penetration Testing In Healthcare: HIPAA And GDPR Requirements
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Enhancing Competitive Intelligence In Pharma With Comprehensive Data Analysis
Discover a unified platform that turns complex pharma data into clear, strategic insights, empowering teams to outpace competitors with evidence-backed decisions from pipeline to launch.
-
Expand Clinical Trial Recruitment With Advanced Analytics And AI
Using advanced analytics and AI can help clinical trial leaders identify and enroll a broader, more diverse patient population, accelerating research.
-
Fujirebio Increases Study Agility By Streamlining Clinical Operations And Data Management Process
Fujirebio’s fast-growing U.S. Clinical R&D team was preparing for shorter studies with higher complexity. Traditional methods using paper and spreadsheet trackers were no longer adequate to meet quality goals. Learn how the group increased its agility and readiness with LifeSphere Clinical EDC and CTMS tools.
-
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers
Explore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
Standardize Vaccine Study Launch Timelines To Just 5 Weeks
Uncover the pre-built vaccine trial solution that delivers quality and predictability for your entire immunology portfolio.
-
How To Overcome The Problem Of The Early ePRO Oversell
In this blog, explore how the approach to PROs needs to be reconsidered, given increasing regulations and trial scrutiny, the clinical need for patient-reported outcomes, and the ability to drive costs down and move off paper.
-
How To Differentiate With A Unified eClinical Solution
Clinical trials are increasingly complex for sites, sponsors, and CROs. In a recent webinar, experts Bill Byrom and Jan Breemans shared how a unified eClinical platform simplifies operations and enhances data quality.
-
A Beginner's Guide To Compliant Electronic Source Data Capture
With today’s complex trials, the expectation of gathering faster results in an increasingly decentralized environment is only increasing, imploring investigators to implement electronic source data capture systems. How can researchers ensure this is done correctly? Leveraging the right technology to standardize a compliant process for source data capture is a proven way to reach these goals.
-
The Importance Of Clinical Research-Focused AI In Data Management
Everyone in clinical research is eager to accelerate progress. Learn how to unlock insights from your data swiftly to accelerate the delivery of safe new therapies.
-
Broadening Eligibility Criteria Among Cancer Clinical Trials Patients
This study challenges the commonly applied exclusionary approach to clinical trials, particularly cancer trials, that underrepresent certain populations and limit the generalizability of research advancements.